Insulet Corporation PODD
$146.75
▲ +0.34% 24H
About
Insulet Corporation is a medical device company specializing in insulin delivery technologies for people living with insulin‑dependent diabetes. The company focuses on its Omnipod platform, a family of tubeless, wearable, pod-based insulin management systems designed to provide continuous subcutaneous insulin infusion …
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited States
Employees5,400
TickerPODD
Statistics
Market Cap$10.16B
Revenue (TTM)$2.71B
Net Income$247.1M
Net Margin9.1%
EPS$3.48
P/E34.86
P/S3.56
P/B7.93
EV/EBITDA18.23
ROE23.0%
Dividend Yield—
Price$146.75
Data: Twelve Data · Revenue = mcap / P/S